20 May 2013
Keywords: astrazeneca, begins, ph, iii, zactima, trial, anglo-swedish
Article | 05 March 2007
Anglo-Swedish drug major AstraZeneca says that it has initiated a Phase III study of its drug Zactima (vandetanib), in combination ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 March 2007
© 2013 thepharmaletter.com